⌘K

Login Start Free

Home/Filings/4/0001213900-25-059864

4//SEC Filing

Kelly Paul Edward 4

Accession 0001213900-25-059864

CIK 0001553643other

View on SEC.gov Company Profile

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 7:27 PM ET

Size

5.5 KB

Accession

0001213900-25-059864

Insider Transaction Report

Form 4

Period: 2025-06-26

RELMADA THERAPEUTICS, INC.RLMD

Kelly Paul Edward

DirectorChief Operating Officer

Transactions

Award
Stock Option (right to buy)
2025-06-26+400,000→ 400,000 total
Exercise: $0.67From: 2025-09-26Exp: 2035-06-26→ Common Stock (400,000 underlying)

Footnotes (1)

[F1]The options vest in 16 equal quarterly installments commencing on September 26, 2025.

Documents

1 file

4
ownership.xmlPrimary

Issuer

RELMADA THERAPEUTICS, INC.

CIK 0001553643

Entity typeother

Related Parties

1

filerCIK 0001658544

Filing Metadata

Form type: 4
Filed: Jun 29, 8:00 PM ET
Accepted: Jun 30, 7:27 PM ET
Size: 5.5 KB

View on SEC.gov